Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Non-invasive blood pressure monitoring in ICU with the DARE device

Official title: Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device

Run by Centre Hospitalier de Saint-Denis · NCT07052123 · Data updated 2026-11-12

This study tests whether the DARE non-invasive monitor can reliably measure blood pressure and other vital signs in adults in the ICU who have invasive arterial and urinary catheters.

More Critical Illness trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2 (estimated)
SponsorCentre Hospitalier de Saint-Denis
Academic / other
Locations1 site (Saint-Denis, France)
StatusRecruiting
StartedMarch 24, 2025
Main results expectedMarch 24, 2028
Study endsMarch 24, 2028
Registry record updatedJuly 4, 2025
Trial IDNCT07052123 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) admitted to the ICU at the enrolling site who are expected to stay more than two days and already have an arterial catheter and urinary catheter are the ideal candidates.

Probably not a fit

Patients without the required invasive catheters, with adhesive or silicone skin allergies, active implanted devices, pregnant or breastfeeding women, minors, or those unable to consent are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares continuous readings from the DARE (MultiSense®) non-invasive hemodynamic monitor with standard invasive arterial pressure and urinary core temperature measurements in adult ICU patients. It records additional signals such as pulse oximetry and cardiac rhythm to see how well the device tracks multiple vital signs. Eligible patients are adults expected to remain in the ICU for more than two days and already have arterial and urinary catheters in place; key exclusions include skin allergy to adhesives, active implanted devices, pregnancy, or legal incapacity to consent. The study is being conducted at Centre Hospitalier de Saint-Denis in France and collects paired invasive and non-invasive measurements for direct comparison.

Why it matters

Potential benefit: If successful, the device could allow accurate, more comfortable hemodynamic monitoring without invasive arterial lines, reducing discomfort and potential catheter-related complications.

How similar studies have gone: Other non-invasive continuous hemodynamic monitors have shown promising but variable accuracy compared with invasive arterial lines, so the approach is partially supported by prior work but not yet universally validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (male or female), aged 18 years or older
* Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days
* Equipped with an arterial catheter for invasive blood pressure monitoring
* Equipped with a urinary catheter for invasive core body temperature monitoring

Exclusion Criteria:

* Patients under 18 years old (minors)
* Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use
* History of extensive skin pathology (e.g., Lyell syndrome)
* Patients with therapeutic limitations
* Patients with active implanted medical devices (e.g., pacemaker, defibrillator)
* Pregnant or breastfeeding women
* Patients not affiliated with the French social security system
* Patients or their legal representatives refusing consent, or unable to understand information and give informed consent
* Patients under legal guardianship, curatorship, or deprived of liberty

Where it's running

  • France
    Saint-Denis, France, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.